显微乳房再造中胸廓内淋巴结活检对多学科决策的影响
该回顾性病例系列纳入2015至2024年自体乳房再造中胸廓内淋巴结(IMLN)阳性的6例患者,评估分期迁移与治疗调整,并结合20项研究4887例的文献综述。结果显示IMLN评估影响全部6例的肿瘤治疗决策,文献中每研究平均阳性检出率为5.7%,多数研究主张常规取样。
要点
- 自体乳房再造中顺带行IMLN活检可改变分期与治疗决策。
- 文献中每研究平均IMLN阳性检出率为5.7%。
- 多数研究(17/20,85.0%)主张血管分离时常规取样。
核心结论
- 自体乳房再造中机会性IMLN活检常改变分期与治疗,鉴于其安全可行,胸廓内血管准备时常规取样值得考虑。
研究设计与样本
- 回顾性病例系列,纳入2015至2024年自体乳房再造中IMLN阳性患者6例,平均年龄50±8.92岁,并同期行PubMed与MEDLINE文献综述。
主要发现
- 6例均为浸润性癌(5例浸润性导管癌、1例浸润性小叶癌),2例为孤立IMLN转移,4例合并腋窝淋巴结累及。
- 术前影像仅1例(16.7%)发现可疑IMLN,病理分期迁移1例(16.7%),但IMLN评估影响全部6例的肿瘤治疗管理。
- 无活检相关并发症。
- 文献汇总20项研究4887例中152例IMLN阳性,每研究平均阳性检出率5.7%。
临床怎么用
- 在胸廓内血管准备过程中可考虑对遇到的IMLN常规取样,以更好支持多学科乳腺癌管理决策。
局限性
- 样本量小(6例),为回顾性病例系列设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Internal mammary lymph nodes (IMLNs) are the second most common site of nodal metastasis in breast cancer, however, they are infrequently sampled in contemporary practice. We report a series of positive IMLNs identified during autologous breast reconstruction and contextualize these findings within the current literature. METHODS: A retrospective case series was conducted of patients with positive IMLN(s) during autologous breast reconstruction between 2015 and 2024. Primary outcome measures included stage migration and modifications to therapy. A concurrent PubMed and MEDLINE literature review was performed. RESULTS: Six patients were included in the study (mean age 50±8.92 years). All patients had invasive carcinoma, including 5 invasive ductal and 1 invasive lobular carcinoma. Two patients had isolated IMLN metastases, and 4 had concomitant axillary nodal involvement. Preoperative imaging visualized a suspicious IMLN in 1 patient (16.7%). Pathologic stage migration occurred in 1 patient (16.7%); however, IMLN assessment influenced oncologic management in all 6 cases. There were no biopsy-related complications. Across 20 published studies and 4887 patients, 152 had positive IMLNs. Twelve studies used selective sampling, and 8 studies employed routine sampling. There was a mean positive IMLN detection of 5.7% per study. Three studies re--ed sampling only suspicious nodes, whereas 17 (85.0%) advocated for routine sampling of all IMLNs encountered during vessel dissection. CONCLUSIONS: Opportunistic IMLN biopsy during autologous breast reconstruction often alters staging and treatment. Given the safety and feasibility of this practice, routine sampling during internal mammary vessel preparation should be considered to better inform multidisciplinary breast cancer management decisions.
引用
- Ogbonnah CO, Allbright ML, Zak A, et al. Impact of internal mammary lymph node biopsy during microsurgical breast reconstruction on multidisciplinary breast cancer management decisions. J Plast Reconstr Aesthet Surg. 2026. PMID: 42250410. doi:10.1016/j.bjps.2026.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。